What is CRISPR Therapeutics's change in AP?

CRISPR Therapeutics (CRSP) reported change in AP of -$13.02M in Q1 2026.

How has CRISPR Therapeutics's change in AP changed year-over-year?

CRISPR Therapeutics's change in AP decreased by 130.3% year-over-year, from $43M to -$13.02M.

What is the long-term trend for CRISPR Therapeutics's change in AP?

Over 2 years (2021 to 2024), CRISPR Therapeutics's change in AP has grown at a -14.7% compound annual growth rate (CAGR), from $37.51M to -$27.28M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

CRISPR Therapeutics CRSP Change in AP

Change in AP at other companies

CG OncologyCGON

$2.52M+1,079%

Cogent Biosciences, Inc.COGT

$4.24M+98.0%

Arrowhead ResearchARWR

$15.26M+397%

BridgeBio PharmaBBIO

-$7.17M-141%

Krystal Biotech, Inc.KRYS

$1.02M+12.8%

Spyre Therapeutics, Inc.SYRE

-$3.21M-206%

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Enterprise value$5.69B+69.8%

P/S1,298.3×+1,208×

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's change in AP?: CRISPR Therapeutics (CRSP) reported change in AP of -$13.02M in Q1 2026.
How has CRISPR Therapeutics's change in AP changed year-over-year?: CRISPR Therapeutics's change in AP decreased by 130.3% year-over-year, from $43M to -$13.02M.
What is the long-term trend for CRISPR Therapeutics's change in AP?: Over 2 years (2021 to 2024), CRISPR Therapeutics's change in AP has grown at a -14.7% compound annual growth rate (CAGR), from $37.51M to -$27.28M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.